PendoPharm Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PendoPharm Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10602
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PendoPharm Inc (PendoPharm), a subsidiary of Pharmascience Inc, is a healthcare company that provides production and commercialization of a wide range of drugs. The company provides products such as spans prescription drugs, over-the-counter and behind-the-counter products, among others. Its prescription product provides drugs for therapeutic areas of gastroenterology, orthopedics and urology. PendoPharm’s OTC and BTC products offer allergy, analgesics, cough, cold and sinus, gastroenterology, nasal care and pediatric drugs, among others. The company also provides licensing, development and marketing late-stage specialty prescription medicines and consumer brands. It markets its products across Canada. Pendopharm is headquartered in Montreal, Quebec, Canada.

PendoPharm Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PendoPharm Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PendoPharm Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PendoPharm Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
PendoPharm Enters into Distribution Agreement with Tillotts Pharma 10
Anika Therapeutics Enters into Agreement with PendoPharm 11
Pendopharm Enters into Distribution Agreement with Sanofi-aventis Canada 12
Licensing Agreements 13
Pendopharm Enters into Licensing Agreement with Edesa Biotech 13
Sigmoid Pharma Enters into Licensing Agreement with PendoPharm for CyCol 14
Paion Exercises Option for Licensing Agreement with PendoPharm for Remimazolam 15
Equity Offering 16
Sigmoid Pharma Raises USD6.3 Million in Private Placement 16
PendoPharm Inc – Key Competitors 17
PendoPharm Inc – Key Employees 18
PendoPharm Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Product News 20
Aug 17, 2017: Introducing the new Lax-A product line for relief of occasional constipation 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
PendoPharm Inc, Pharmaceuticals & Healthcare, Key Facts 2
PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PendoPharm Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PendoPharm Inc, Deals By Therapy Area, 2012 to YTD 2018 8
PendoPharm Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PendoPharm Enters into Distribution Agreement with Tillotts Pharma 10
Anika Therapeutics Enters into Agreement with PendoPharm 11
Pendopharm Enters into Distribution Agreement with Sanofi-aventis Canada 12
Pendopharm Enters into Licensing Agreement with Edesa Biotech 13
Sigmoid Pharma Enters into Licensing Agreement with PendoPharm for CyCol 14
Paion Exercises Option for Licensing Agreement with PendoPharm for Remimazolam 15
Sigmoid Pharma Raises USD6.3 Million in Private Placement 16
PendoPharm Inc, Key Competitors 17
PendoPharm Inc, Key Employees 18

List of Figures
PendoPharm Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PendoPharm Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PendoPharm Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PendoPharm Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • UPM-Kymmene Corporation:企業の戦略・SWOT・財務情報
    UPM-Kymmene Corporation - Strategy, SWOT and Corporate Finance Report Summary UPM-Kymmene Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Santos Limited:企業のM&A・事業提携・投資動向
    Santos Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Santos Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • The E. W. Scripps Company:企業の戦略・SWOT・財務情報
    The E. W. Scripps Company - Strategy, SWOT and Corporate Finance Report Summary The E. W. Scripps Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • BioMarin Pharmaceutical Inc (BMRN):企業の財務・戦略的SWOT分析
    BioMarin Pharmaceutical Inc (BMRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Etiqa General Insurance Berhad:企業の戦略的SWOT分析
    Etiqa General Insurance Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Pacific Energy Ltd (PEA):企業の財務・戦略的SWOT分析
    Summary Pacific Energy Ltd (PEL) operates as a power generation company that develops, operates and maintains renewable energy power stations. The company operates Kalgoorlie Power Systems that operates site locations across Northern Territory, Western Australia and South Australia, among others. It …
  • ACell Inc:企業の製品パイプライン分析
    Summary ACell Inc (ACell) is a medical device company that offers products for wounds and various surgical procedures. The company develops and manufactures products to facilitate the body’s ability to repair and remodel tissue. Its products portfolio includes burn matrix products, multilayer wound …
  • Medicines for Malaria Venture:製薬・医療:M&Aディール及び事業提携情報
    Summary Medicines for Malaria Venture (MMV) is a drug developing company that discovers and delivers new, effective and affordable antimalarial drugs. The center provides products that offers efficacy against drug-resistant strains of plasmodium falciparum, potential for intermittent treatments, saf …
  • GATT Technologies BV:製品パイプライン分析
    Summary GATT Technologies BV (GATT Technologies) is a medical technology company, which develops synthetic surgical hemostat and sealant products that control severe bleeding. Its product pipeline includes GATT-Patch for controlling excessive bleeding; GATT-Tape for blocking intestinal anastomotic l …
  • Takara Holdings Inc.:企業の戦略・SWOT・財務情報
    Takara Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Takara Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Allison Transmission Holdings Inc:企業の戦略・SWOT・財務情報
    Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Barracuda Networks, Inc.:企業の戦略・SWOT・財務情報
    Barracuda Networks, Inc. - Strategy, SWOT and Corporate Finance Report Summary Barracuda Networks, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • American Woodmark Corp (AMWD):企業の財務・戦略的SWOT分析
    American Woodmark Corp (AMWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Grupo Ferrer Internacional SA:企業の戦略・SWOT・財務情報
    Grupo Ferrer Internacional SA - Strategy, SWOT and Corporate Finance Report Summary Grupo Ferrer Internacional SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Marriott International Inc:戦略・SWOT・企業財務分析
    Marriott International Inc - Strategy, SWOT and Corporate Finance Report Summary Marriott International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • IOI Corporation Berhad:企業の戦略・SWOT・財務分析
    IOI Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary IOI Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Info Edge (India) Limited:企業のM&A・事業提携・投資動向
    Info Edge (India) Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Info Edge (India) Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • GenomicTree Co Ltd (228760):企業の製品パイプライン分析
    Summary GenomicTree Co Ltd (GenomicTree) is a medical device company that develops and commercializes diagnostic products for the screening and diagnosis of cancer. The company also provides non-invasive cancer molecular diagnostic product. Its products are used in the detection of colorectal, lung …
  • Peet’s Coffee & Tea Inc:企業の戦略・SWOT・財務情報
    Peet's Coffee & Tea Inc - Strategy, SWOT and Corporate Finance Report Summary Peet's Coffee & Tea Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • USANA Health Sciences Inc (USNA):企業の財務・戦略的SWOT分析
    USANA Health Sciences Inc (USNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆